- Home
- SVRE vs NTBL Comparison
SVRE vs NTBL Comparison
Compare SVRE & NTBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRE
- NTBL
- Stock Information
- Founded
- SVRE 2014
- NTBL 2000
- Country
- SVRE Israel
- NTBL United States
- Employees
- SVRE N/A
- NTBL N/A
- Industry
- SVRE
- NTBL Biotechnology: Pharmaceutical Preparations
- Sector
- SVRE
- NTBL Health Care
- Exchange
- SVRE Nasdaq
- NTBL Nasdaq
- Market Cap
- SVRE 6.6M
- NTBL 6.6M
- IPO Year
- SVRE 2022
- NTBL N/A
- Fundamental
- Price
- SVRE $0.16
- NTBL $0.47
- Analyst Decision
- SVRE
- NTBL Strong Buy
- Analyst Count
- SVRE 0
- NTBL 2
- Target Price
- SVRE N/A
- NTBL $7.00
- AVG Volume (30 Days)
- SVRE 2.5M
- NTBL 51.1K
- Earning Date
- SVRE 08-27-2024
- NTBL 08-14-2024
- Dividend Yield
- SVRE N/A
- NTBL N/A
- EPS Growth
- SVRE N/A
- NTBL N/A
- EPS
- SVRE N/A
- NTBL N/A
- Revenue
- SVRE $458,952.00
- NTBL $313,000.00
- Revenue This Year
- SVRE $219.30
- NTBL N/A
- Revenue Next Year
- SVRE $148.59
- NTBL N/A
- P/E Ratio
- SVRE N/A
- NTBL N/A
- Revenue Growth
- SVRE N/A
- NTBL 3812.50
- 52 Week Low
- SVRE $0.16
- NTBL $0.45
- 52 Week High
- SVRE $1.50
- NTBL $10.08
- Technical
- Relative Strength Index (RSI)
- SVRE 29.81
- NTBL 35.47
- Support Level
- SVRE $0.18
- NTBL $0.45
- Resistance Level
- SVRE $0.18
- NTBL $0.54
- Average True Range (ATR)
- SVRE 0.02
- NTBL 0.06
- MACD
- SVRE -0.00
- NTBL -0.01
- Stochastic Oscillator
- SVRE 5.45
- NTBL 2.63
About SVRE SaverOne 2014 Ltd.
Saverone 2014 Ltd provides driver protection solutions. The company develops and deploys ADAS technologies for transportation safety and driver assistance. The company's product restricts the driver from surfing, communicating, and receiving alerts while driving. The Company has developed a system that provides a solution to the problem of distracted driving caused by cell phone use, which endangers the driver, passengers, other drivers on the road, and pedestrians.
About NTBL Notable Labs Ltd.
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.